Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Qiaoli Gu
ICIs have bettered progression-free and overall survival of numerous cases with different types of cancer. With recent studies demonstrating the remedial benefit of ICIs either as a single agent or in combination with other ICIs or nephrotoxic cancer agents (e.g., platinum or vascular endothelial growth factor impediments), ICI curatives are being used more constantly. still, these curatives are known to induce seditious towel damage, causing vulnerable-affiliated adverse events (irAEs) 2 which can do in over to 80 of cases treated withICI.3 Overall, prevalence of AKI in cases entering immunotherapy can reach up to 17 with 2 to 5 estimated to be directly attributable to immunotherapy.4, 5 Programmed cell death protein 1 or programmed cell death ligand 1 signaling pathway, or the cytotoxic T lymphocyte antigen 4 signaling pathway leaguer by monoclonal antibodies breaks vulnerable forbearance by unleashing inert towel-specific tone- reactive T cells, leading to T- cell dysregulation and development of irAEs